Nucana Plc ADR (NCNA) Stock Price, Quote & News

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 13 1357 1111

Website: www.nucana.com

Address:

3 Lochside Way, Edinburgh, United Kingdom

StockPacer Jul. 26 at 9:28 PM

$NCNA Your Life Is About to Change. All your debts will be paid off, and you will have enough left over to make a downpayment on the house of your dreams $0.14 -> $0.36 -> $0.55->$1+ For reference, see IXHL.

1 · Reply

4MYT Jul. 26 at 9:22 PM

$NCNA As of 7/24, many of the big traders on X w/ followers in the ten's of thousands alerted $NCNA, and loading as of early market on 7/25.

0 · Reply

NovaDog697 Jul. 26 at 9:07 PM

$IXHL and $NCNA HODL

1 · Reply

_username_ Jul. 26 at 9:05 PM

$NCNA lift off incoming 🚀

0 · Reply

ArcturusStocks Jul. 26 at 9:03 PM

$NCNA most ppl on this board have no clue on what's about to be revealed or what's happening behind the scenes. It goes beyond charts and percentages. It's about to get crazy from here on out so buckle up..

2 · Reply

Rum3002576 Jul. 26 at 9:02 PM

$NCNA 💥

0 · Reply

OOVERCOMER Jul. 26 at 8:56 PM

$NCNA has the potential of doing 2000%, after canceling the warrants.

1 · Reply

BenedictArthurKnight Jul. 26 at 8:38 PM

$NCNA warrants eliminated. Built up some hype to close out the week. Top watch early next week. We saw what $IXHL just did after they eliminated warrants 👀

1 · Reply

cheddahcrypto Jul. 26 at 8:35 PM

$NCNA I agree!

0 · Reply

Idunno_untiliknow Jul. 26 at 8:31 PM

$NCNA Impressive book/share price, especially for having negative income. Too many unknown variables on this for me. I maybe missing the boat on a run up, but based on the stats I'll wait to get in until after the 1/200 reverse split sometime around August 8th. GL!

0 · Reply

NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jul 11, 2025, 10:30 AM EDT - 15 days ago

NuCana Announces Plan to Implement ADS Ratio Change

Jun 2, 2025, 4:01 PM EDT - 7 weeks ago

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Mar 20, 2025, 4:01 PM EDT - 4 months ago

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Feb 10, 2025, 7:00 AM EST - 5 months ago

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Nov 25, 2024, 7:00 AM EST - 8 months ago

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 11, 2024, 7:00 AM EST - 9 months ago

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Oct 4, 2024, 12:03 PM EDT - 10 months ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Sep 25, 2024, 4:01 PM EDT - 10 months ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

$NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024$

Sep 14, 2024, 3:01 AM EDT - 11 months ago

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Aug 29, 2024, 4:01 PM EDT - 11 months ago

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

Aug 15, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

May 30, 2024, 8:36 AM EDT - 1 year ago

NuCana to Present at the Jefferies Global Healthcare Conference

May 21, 2024, 8:00 AM EDT - 1 year ago

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

May 16, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

May 1, 2024, 4:01 PM EDT - 1 year ago

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

Apr 9, 2024, 4:30 PM EDT - 1 year ago

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

Mar 20, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Feb 27, 2024, 8:00 AM EST - 1 year ago

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

Jan 3, 2024, 2:39 AM EST - 1 year ago

NuCana: Potential Turnaround In 2024 But Risky

Nov 16, 2023, 4:01 PM EST - 1 year ago

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 10, 2023, 4:01 PM EST - 1 year ago

NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 8, 2023, 4:01 PM EST - 1 year ago

NuCana to Present at the Jefferies London Healthcare Conference

Nov 1, 2023, 4:01 PM EDT - 1 year ago

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

Oct 16, 2023, 7:00 AM EDT - 1 year ago

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 13, 2023, 12:30 PM EDT - 1 year ago

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Aug 16, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

Jun 1, 2023, 8:00 AM EDT - 2 years ago

NuCana to Present at the Jefferies Healthcare Conference

May 17, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

May 12, 2023, 4:01 PM EDT - 2 years ago

NuCana Announces Receipt of Nasdaq Notice

Apr 14, 2023, 8:00 AM EDT - 2 years ago

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

Apr 4, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Mar 24, 2023, 4:30 PM EDT - 2 years ago

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

Feb 28, 2023, 8:00 AM EST - 2 years ago

NuCana to Participate in Two Upcoming Investor Conferences

Jan 8, 2023, 4:30 AM EST - 2 years ago

NuCana: Pipeline And Major Gilead Litigation Progressing Nicely

Jan 6, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Receipt of NASDAQ Notice

Nov 16, 2022, 4:01 PM EST - 2 years ago

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Oct 26, 2022, 7:00 AM EDT - 2 years ago

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

Sep 22, 2022, 3:40 PM EDT - 3 years ago

NuCana: An Intriguing 'Sum Of The Parts' Story

Sep 12, 2022, 10:45 AM EDT - 3 years ago

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Sep 6, 2022, 8:00 AM EDT - 3 years ago

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

Aug 31, 2022, 8:00 AM EDT - 3 years ago

NuCana to Participate in Citi's 17th Annual BioPharma Conference

Aug 17, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

Jul 13, 2022, 6:00 AM EDT - 3 years ago

NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead

Jul 11, 2022, 1:52 PM EDT - 3 years ago

Why NuCana Shares Are Rising Today?

Jul 11, 2022, 8:00 AM EDT - 3 years ago

German Court Rules that Gilead's Sofosbuvir Infringes NuCana's ‘190 Patent

Jun 10, 2022, 7:00 AM EDT - 3 years ago

NuCana Announces Presentation on NUC-7738 at the European Hematology Association (EHA) 2022 Hybrid Congress

Jun 2, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports First Quarter 2022 Financial Results and Provides Business Update

Jun 1, 2022, 4:01 PM EDT - 3 years ago

NuCana to Participate in the 2022 Jefferies Healthcare Conference

StockPacer Jul. 26 at 9:28 PM

1 · Reply

4MYT Jul. 26 at 9:22 PM

$NCNA As of 7/24, many of the big traders on X w/ followers in the ten's of thousands alerted $NCNA, and loading as of early market on 7/25.

0 · Reply

NovaDog697 Jul. 26 at 9:07 PM

$IXHL and $NCNA HODL

1 · Reply

_username_ Jul. 26 at 9:05 PM

$NCNA lift off incoming 🚀

0 · Reply

ArcturusStocks Jul. 26 at 9:03 PM

2 · Reply

Rum3002576 Jul. 26 at 9:02 PM

$NCNA 💥

0 · Reply

OOVERCOMER Jul. 26 at 8:56 PM

$NCNA has the potential of doing 2000%, after canceling the warrants.

1 · Reply

BenedictArthurKnight Jul. 26 at 8:38 PM

$NCNA warrants eliminated. Built up some hype to close out the week. Top watch early next week. We saw what $IXHL just did after they eliminated warrants 👀

1 · Reply

cheddahcrypto Jul. 26 at 8:35 PM

$NCNA I agree!

0 · Reply

Idunno_untiliknow Jul. 26 at 8:31 PM

0 · Reply

Dansaidso Jul. 26 at 8:23 PM

$NCNA RS is closer to a promise than a threat. It’s going to happen. Would take a near miracle to prevent it. Plenty of room to run between now and then. A lot of these plays give their most just pre split, then usually a chance to renter and play just post split.

0 · Reply

Ryancoll Jul. 26 at 8:17 PM

$NCNA one week chart looks bullish 🐂 probably gonna pop soon

0 · Reply

Chase_me03 Jul. 26 at 8:08 PM

$NCNA Guys all we need to do is let fear not get the good of us! If we all vow to not sell a single share the shorts will be toast and this could turn out to be once in a lifetime opportunity! GME 2.0

0 · Reply

RocketPoweredBaldEagle Jul. 26 at 8:06 PM

$NCNA I need .35

0 · Reply

NIVOLOCO Jul. 26 at 8:05 PM

$NCNA 🔥 Ain’t selling shit !

0 · Reply

BOUDIN420 Jul. 26 at 7:59 PM

$NCNA TQ w/ DD https://x.com/QueTraders/status/1949143274804900166

0 · Reply

Chrille20 Jul. 26 at 7:55 PM

$NCNA got in at .0593 let’s see if we get some next week

1 · Reply

billionaire128 Jul. 26 at 7:51 PM

$NCNA The key with this stock like 1 other 1 I am involve (HCTI) with is the share HOLDERS have a BOND and a POINT to PROVE.. we are not WEAK... stock is not a waste of time and SHORTS MESS with THE WRONG 1

0 · Reply

1Knevrenuff Jul. 26 at 7:41 PM

$NCNA ...if your new...Warrant cancelation...r/s threat to mess with shorts...CASH RUNWAY Q4 2026...no dilution necessary...promising pipeline

0 · Reply

Abovedarest40 Jul. 26 at 7:26 PM

$NCNA show me 0.20 on monday

0 · Reply

UCF_16 Jul. 26 at 7:23 PM

$GIBO $HCTI $NCNA $WLGS $WLGS for the win! 🚀🎆🔥

1 · Reply

UCF_16 Jul. 26 at 7:22 PM

$GIBO $HCTI $NCNA $WLGS $WLGS for the win!🏆

0 · Reply

Market Cap	328,000.00
Revenue (ttm)	0.00
Net Income (ttm)	-24.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	515,624,031
Avg Vol	270,399,594
Day's Range	N/A - N/A
Shares Out	6.08M
Stochastic %K	74%
Beta	1.42
Analysts	Strong Buy
Price Target	$25.00